Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?
Authors:
Open Access
- 5 July 2012
- journal article
- Published by Hindawi Limited in ISRN Endocrinology
- Vol. 2012, 1-5
Abstract
Aims. We compared the demographic profile and clinical characteristics of individuals with new onset steroid-induced diabetes (NOSID) to Type 2 diabetes (T2DM) patients with and without steroid treatment. Methods. The demographic profile and clinical characteristics of 60 individuals who developed NOSID were examined and matched to 60 type 2 diabetes patients receiving steroid therapy (T2DM+S) and 360 diabetic patients not on steroids (T2DM) for age, duration of diabetes, HbA1c, gender, and ethnicity. Results. Patients who developed NOSID had less family history of diabetes () and were less overweight (). NOSID was more commonly treated with insulin. Despite a matching duration of diabetes and glycaemic control, significantly less retinopathy was found in the group of patients with NOSID (). Conclusions. It appears that steroid treatment primarily precipitated diabetes in a group of individuals otherwise less affected by risk factors of diabetes at that point in time, rather than just opportunistically unmasking preexisting diabetes. Furthermore, the absence of retinopathy suggests that patients with NOSID had not been exposed to long periods of hyperglycaemia. However, the impact of the underlying conditions necessitating steroid treatment and concomitant medications such as immunosuppressants on diabetes development remain to be defined.
Keywords
This publication has 54 references indexed in Scilit:
- Detailed family history of diabetes identified children at risk of type 2 diabetes: a population-based case-control studyPediatric Diabetes, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- New-Onset Diabetes Mellitus in the Kidney RecipientClinical Journal of the American Society of Nephrology, 2008
- Management of Diabetic RetinopathyJAMA, 2007
- The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention ProgramDiabetic Medicine, 2007
- Management of Diabetes and Hyperglycemia in HospitalsDiabetes Care, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.Journal of Clinical Investigation, 1997
- POSTTRANSPLANT HYPERGLYCEMIATransplantation, 1989
- Clinical Features of the Diabetic Syndrome Appearing after Steroid TherapyPostgraduate Medical Journal, 1964